Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 10, 2013
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Photomedex Inc
| -30.00K |
$16.13 | -$483,811.00 | -2.90% | 1.01M |
Sep 6 - Sep 10
| |||||||
Photomedex Inc
| -30.00K |
$16.01 | -$480,181.00 | -2.82% | 1.04M |
Sep 3 - Sep 5
| |||||||
Photomedex Inc
| -25.00K |
$16.27 | -$406,682.50 | -2.29% | 1.07M |
Aug 28 - Aug 30
| |||||||
Photomedex Inc
| -35.00K |
$16.34 | -$571,980.50 | -3.11% | 1.09M |
Aug 23 - Aug 27
| |||||||
Photomedex Inc
| -45.00K |
$15.94 | -$717,168.00 | -3.85% | 1.13M |
Aug 20 - Aug 22
| |||||||
Photomedex Inc
| -35.00K |
$14.91 | -$521,886.50 | -2.90% | 1.17M |
Aug 15 - Aug 19
| |||||||
Photomedex Inc
| 428.57K |
—
|
—
| +39.08% | 1.53M |
Nov 16
| |||||||
Photomedex Inc
| -214.28K |
—
|
—
| -16.35% | 1.1M |
Sep 6
| |||||||
Photomedex Inc
| -214.28K |
—
|
—
| -14.05% | 1.31M |
Sep 5
| |||||||
Photomedex Inc
| 5K |
$13.50 | $67,500.00 | +0.33% | 1.53M |
Jan 26
| |||||||
Photomedex Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Vision Sciences Inc /de/
|
0
|
—
|
—
|
—
|
0
|
Sep 2
| |||||||
Vision Sciences Inc /de/
|
0
|
—
|
—
|
—
|
0
|
Sep 3
| |||||||
Vision Sciences Inc /de/
|
0
|
—
|
—
|
—
|
0
|
Aug 28
| |||||||
Vision Sciences Inc /de/
|
0
|
—
|
—
|
—
|
0
|
May 29
| |||||||
Vision Sciences Inc /de/
| -31.39K |
—
|
—
| -0.38% | 8.19M |
Apr 21
| |||||||
Vision Sciences Inc /de/
| 370.37K |
$2.70 | $999,999.00 | +4.72% | 8.22M |
Feb 14
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||